What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures study
What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures study
Rationale: asbestos is posited to cause otherwise ‘idiopathic’ pulmonary fibrosis (IPF); establishing this has important diagnostic and therapeutic implications.
Objectives: to determine the association between occupational asbestos exposure and IPF; to investigate interaction with MUC5B rs35705950 genotype.
Methods: multi-centre, incident case-control study. Cases (n=494) were men diagnosed with IPF at 21 United Kingdom hospitals. Controls (n=466) were age-matched men who attended a hospital clinic in the same period. Asbestos exposure was measured using a validated job exposure matrix and a source-receptor model. The primary outcome was the association between asbestos exposure and IPF, estimated using logistic regression adjusted for age, smoking and centre. Interaction with MUC5B rs3570950 was investigated using a genetic dominant model.
Measurements and main results: 327 (66%) cases and 293 (63%) controls ever had a high or medium asbestos exposure risk job; 8% of both cases and controls, had cumulative exposure estimates ≥ 25 fibre.ml−1.years. Occupational asbestos exposure was not associated with IPF, adjusted OR 1.1(95%CI 0.8-1.4; p=0.6) and there was no gene-environment interaction (p=0.2). Ever smoking was associated with IPF, OR 1.4 (95%CI 1-1.9; p=0.04). When stratifying for genotype there was significant interaction between smoking and work in an exposed job (p<0.01) for carriers of the minor allele of MUC5B rs3570950.
Conclusions: occupational asbestos exposure alone, or through interaction with MUC5B rs35705950 genotype, was not associated with IPF. However, exposure to asbestos and smoking interact to increase IPF risk in carriers of the minor allele of MUC5B rs3570950.
Clinical trial registered with www.clinicaltrials.gov (NCT03211507).
Reynolds, Carl J.
d9a65e2f-76d3-4b1c-be03-73c563244fe0
Sisodia, Rupa
6669f5f6-03d3-4468-b89e-4b1196dffef6
Barber, Chris
05963f71-956f-417a-b9fe-1feefea720c1
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe
12 March 2021
Reynolds, Carl J.
d9a65e2f-76d3-4b1c-be03-73c563244fe0
Sisodia, Rupa
6669f5f6-03d3-4468-b89e-4b1196dffef6
Barber, Chris
05963f71-956f-417a-b9fe-1feefea720c1
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe
[Unknown type: UNSPECIFIED]
Abstract
Rationale: asbestos is posited to cause otherwise ‘idiopathic’ pulmonary fibrosis (IPF); establishing this has important diagnostic and therapeutic implications.
Objectives: to determine the association between occupational asbestos exposure and IPF; to investigate interaction with MUC5B rs35705950 genotype.
Methods: multi-centre, incident case-control study. Cases (n=494) were men diagnosed with IPF at 21 United Kingdom hospitals. Controls (n=466) were age-matched men who attended a hospital clinic in the same period. Asbestos exposure was measured using a validated job exposure matrix and a source-receptor model. The primary outcome was the association between asbestos exposure and IPF, estimated using logistic regression adjusted for age, smoking and centre. Interaction with MUC5B rs3570950 was investigated using a genetic dominant model.
Measurements and main results: 327 (66%) cases and 293 (63%) controls ever had a high or medium asbestos exposure risk job; 8% of both cases and controls, had cumulative exposure estimates ≥ 25 fibre.ml−1.years. Occupational asbestos exposure was not associated with IPF, adjusted OR 1.1(95%CI 0.8-1.4; p=0.6) and there was no gene-environment interaction (p=0.2). Ever smoking was associated with IPF, OR 1.4 (95%CI 1-1.9; p=0.04). When stratifying for genotype there was significant interaction between smoking and work in an exposed job (p<0.01) for carriers of the minor allele of MUC5B rs3570950.
Conclusions: occupational asbestos exposure alone, or through interaction with MUC5B rs35705950 genotype, was not associated with IPF. However, exposure to asbestos and smoking interact to increase IPF risk in carriers of the minor allele of MUC5B rs3570950.
Clinical trial registered with www.clinicaltrials.gov (NCT03211507).
Text
2021.03.09.21253224v1.full
- Author's Original
More information
Published date: 12 March 2021
Identifiers
Local EPrints ID: 491383
URI: http://eprints.soton.ac.uk/id/eprint/491383
PURE UUID: b928fe1c-6a9a-44ce-96fd-f2cb4bfc6d7c
Catalogue record
Date deposited: 21 Jun 2024 16:33
Last modified: 21 Sep 2024 02:15
Export record
Altmetrics
Contributors
Author:
Carl J. Reynolds
Author:
Rupa Sisodia
Author:
Chris Barber
Author:
Sophie Fletcher
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics